<DOC>
	<DOC>NCT00965081</DOC>
	<brief_summary>The main purpose of this study is to determine if 30 milligrams (mg) of duloxetine is effective in the treatment of fibromyalgia compared to placebo.</brief_summary>
	<brief_title>A Study for Adult Patients With Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Meet study criteria for fibromyalgia diagnosis. Have previously or are currently taking duloxetine. Have been diagnosed with certain psychoses, bipolar or schizoaffective disorder Have pain symptoms that are difficult to differentiate from fibromyalgia. Have seizure disorder, uncontrolled narrow angle glaucoma, or acute liver injury (such as hepatitis) or severe cirrhosis. Have had any primary Axis 1 diagnosis other than major depressive disorder or generalized anxiety disorder within the past year. Are pregnant or breastfeeding Have a current or previous diagnosis of rheumatoid, infectious or inflammatory arthritis or an autoimmune disease Have a regional pain syndrome, failed back syndrome or chronic localized pan related to any past surgery Have a serious unstable medical illness Have a history of substance abuse or dependence within the past year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>